In the BioHarmony Drug Report Database

"Preview" Icon

Vigabatrin

Sabril, Kigabeq (vigabatrin) is a small molecule pharmaceutical. Vigabatrin was first approved as Sabril on 2009-08-21. It is used to treat complex partial epilepsy, epilepsy, and infantile spasms in the USA. It has been approved in Europe to treat infantile spasms and partial epilepsies. The pharmaceutical is active against 4-aminobutyrate aminotransferase, mitochondrial. In addition, it is known to target vesicular inhibitory amino acid transporter.

 

Trade Name

 

Kigabeq
 

Common Name

 

vigabatrin
 

ChEMBL ID

 

CHEMBL89598
 

Indication

 

complex partial epilepsy, epilepsy, infantile spasms, partial epilepsies
 

Drug Class

 

Gabamimetics

Image (chem structure or protein)

Vigabatrin structure rendering